Arjuna Bark

Arjuna bark contains several bioactive compounds, including arjunic acid, arjunolic acid, and tannins, which contribute to its cardiovascular effects. These constituents appear to strengthen cardiac muscle fibers, improve coronary artery blood flow, and provide antioxidant protection to heart tissue. Research suggests Arjuna may enhance the heart's pumping efficiency and support healthy blood pressure regulation through multiple pathways. The herb also demonstrates lipid-modulating properties that may contribute to its overall cardiovascular benefits. Evidence Level: C.

Arjuna bark requires caution when combined with antihypertensive medications, blood thinners, and other cardiac drugs. Because Arjuna has documented blood pressure-lowering properties, combining it with prescription antihypertensives may cause additive effects, potentially leading to hypotension. Similarly, Arjuna may interact with blood-thinning medications, affecting clotting times. If you take beta-blockers, ACE inhibitors, calcium channel blockers, or anticoagulants, consult a qualified healthcare provider before adding Arjuna. Regular monitoring of blood pressure and cardiac parameters is advisable when using this herb alongside conventional treatments.

Traditional Ayurvedic practice and clinical studies typically use Arjuna bark at doses of 500mg of bark powder taken three times daily, or 500mg of standardized extract taken twice daily. Standardized extracts are often prepared to concentrate specific active constituents like arjunic acid. Dosage may vary based on the formulation and the condition being addressed. Always follow product label instructions and consult a qualified healthcare practitioner for personalized dosing recommendations, particularly if you have existing cardiovascular conditions or are taking other medications.

Arjuna bark is considered unsafe during pregnancy and should be avoided. Traditional Ayurvedic texts and modern safety assessments classify Arjuna as contraindicated for pregnant women. Due to insufficient safety data and the herb's cardiovascular activity, breastfeeding women should also avoid Arjuna supplementation. Women who are pregnant, planning pregnancy, or nursing should consult their healthcare provider before using any herbal supplements, particularly those with documented cardiac effects.

Arjuna bark has been used in Ayurvedic medicine for over 2,000 years as the premier cardiac tonic. Traditional applications include supporting cardiac weakness, managing angina pectoris, addressing bleeding disorders, and promoting overall cardiovascular health. Modern clinical research has explored Arjuna for congestive heart failure, coronary heart disease, hypertension, and cholesterol reduction. Studies suggest it may help reduce angina frequency and improve exercise tolerance in cardiac patients. Evidence Level: C, indicating promising but preliminary clinical data. Arjuna should complement, not replace, conventional cardiac care under medical supervision.